9-anilinoacridine has been researched along with amsacrine in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (26.19) | 18.7374 |
1990's | 11 (26.19) | 18.2507 |
2000's | 12 (28.57) | 29.6817 |
2010's | 5 (11.90) | 24.3611 |
2020's | 3 (7.14) | 2.80 |
Authors | Studies |
---|---|
Baguley, BC; Cain, BF; Denny, WA | 1 |
Atwell, GJ; Cain, BF; Denny, WA | 1 |
Atwell, GJ; Cain, BF; Denny, WA; Hansch, C; Leo, A; Panthananickal, A | 1 |
Denny, WA; Henry, DR; Jurs, PC | 1 |
Croft, SL; Denny, WA; Figgitt, DP; Gamage, SA; Mauel, J; Ralph, RK; Ransijn, A; Snowdon, D; Wojcik, SJ; Yardley, V | 1 |
Cain, BF; Denny, WA; Roberts, PB | 1 |
Baguley, BC; Ferguson, LR; Iwamoto, Y; Pearson, A | 1 |
Denny, WA; Ferguson, LR; Iwamoto, Y; Kurita, A; Pogai, HB; Uzuhashi, T; Yangihara, Y | 1 |
Baguley, BC; Denny, WA; Johnson, P; Lee, HH; McFadyen, WD; Palmer, BD; Wakelin, LP; Wickham, G | 1 |
Ames, JR; Kovacic, P; Ryan, MD | 1 |
Klopman, G; Macina, OT | 1 |
Atwell, GJ; Baguley, BC; Denny, WA; Rewcastle, GW | 1 |
Baguley, BC; Nash, R | 1 |
Baguley, BC; Ferguson, LR | 1 |
Baguley, BC; Denny, WA; Robertson, IG | 1 |
Khan, MN; Kuliya-Umar, AF | 1 |
Denny, WA; Figgitt, DP; Gamage, SA; Ralph, RK | 1 |
Chavalitshewinkoon, P; Denny, W; Figgitt, D; Gamage, S; Ralph, R; Wilairat, P | 1 |
Denny, W; Figgitt, D; Gamage, S; Mauël, J; Ralph, R; Ransijn, A; Wojcik, S | 1 |
Denny, WA; Gao, H; Garg, R; Hansch, C | 1 |
Madden, B; McClean, S; McGown, AT; Searcey, M; Wakelin, LP | 1 |
Boyd, M; Denny, WA; Fan, JY; Ohms, SJ | 1 |
Auparakkitanon, S; Wilairat, P | 1 |
Beal, PA; Carlson, CB | 2 |
Chen, IL; Chen, YL; Lu, CM; Tsao, LT; Wang, JP | 1 |
Baguley, BC; Jacintho, JD; Kovacic, P; Wakelin, LP | 1 |
Auparakkitanon, S; Denny, WA; Noonpakdee, W; Ralph, RK; Wilairat, P | 1 |
Bacherikov, VA; Chen, CH; Chou, TC; Dong, HJ; Lin, YW; Su, TL; Tsai, TJ | 1 |
Bacherikov, VA; Chen, CH; Chou, TC; Dong, HJ; Lee, RZ; Lin, YW; Liu, LF; Su, TL; Tsai, TJ; Zhang, X | 1 |
Alonso, C; Castilla, J; Fuertes, MA; Nguewa, PA; Pérez, JM | 1 |
Chen, YT; Chou, TC; Kakadiya, R; Kapuriya, K; Kapuriya, N; Lee, TC; Naliapara, Y; Shah, A; Su, TL; Tsai, TH; Wu, YT; Zhang, X | 1 |
Chen, CH; Chou, TC; Kakadiya, R; Kapuriya, N; Lin, YW; Su, TL; Tsai, TJ; Zhang, X | 1 |
Chauhan, PM; Kumar, A; Puri, SK; Raja Kumar, S; Srivastava, K | 1 |
Hrubý, M; Kaňková, D; Kovář, J; Sedláček, O; Studenovský, M; Svoboda, J; Ulbrich, K; Větvička, D | 1 |
Jubie, S; Kalirajan, R; Kulshrestha, V; Sankar, S | 1 |
Cheng, P; Luo, T; Wang, J; Wang, Z; Zhang, Y; Zhao, J | 1 |
Gaurav, K; Gowramma, B; Kalirajan, R; Pandiselvi, A; Sankar, S | 1 |
Balachandran, P; Gowramma, B; Kalirajan, R; Pandiselvi, A | 1 |
Egarmina, K; Gellerman, G; Grynszpan, F; Hershkovitz-Rokah, O; Shpilberg, O; Tuchinsky, H; Walunj, D | 1 |
Byran, G; Gomathi, S; Rajagopal, K; Sri, VB | 1 |
Chen, ZS; Gupta, P; Kumar, RV; Kwon, CH | 1 |
2 review(s) available for 9-anilinoacridine and amsacrine
Article | Year |
---|---|
Mechanisms of action of DNA intercalating acridine-based drugs: how important are contributions from electron transfer and oxidative stress?
Topics: Acridines; Amsacrine; Antineoplastic Agents; DNA; Electron Transport; Humans; Intercalating Agents; Neoplasms; Oxidative Stress | 2003 |
Anticancer compounds as leishmanicidal drugs: challenges in chemotherapy and future perspectives.
Topics: Amsacrine; Animals; Antineoplastic Agents; Antiprotozoal Agents; Apoptosis; Humans; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Organoplatinum Compounds; Oxyquinoline; Phospholipids; Topoisomerase II Inhibitors | 2008 |
40 other study(ies) available for 9-anilinoacridine and amsacrine
Article | Year |
---|---|
Potenial antitumor agents. 28. Deoxyribonucleic acid polyintercalating agents.
Topics: Acridines; Animals; Antineoplastic Agents; Bacteriophages; DNA; DNA, Superhelical; DNA, Viral; Leukemia L1210; Leukemia, Experimental; Mice; Nucleic Acid Conformation; Structure-Activity Relationship | 1978 |
Potential antitumor agents. 17. 9-Anilino-10-methylacridinium salts.
Topics: Acridines; Aniline Compounds; Animals; Antineoplastic Agents; Leukemia L1210; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Quaternary Ammonium Compounds; Structure-Activity Relationship | 1976 |
Potential antitumor agents. 36. Quantitative relationships between experimental antitumor activity, toxicity, and structure for the general class of 9-anilinoacridine antitumor agents.
Topics: Aminoacridines; Antineoplastic Agents; Chemical Phenomena; Chemistry; Chemistry, Physical; Electrons; Kinetics; Models, Chemical; Molecular Conformation; Structure-Activity Relationship | 1982 |
Structure-antitumor activity relationships of 9-anilinoacridines using pattern recognition.
Topics: Aminoacridines; Antineoplastic Agents; Chemical Phenomena; Chemistry, Physical; Models, Molecular; Molecular Conformation; Pattern Recognition, Automated; Structure-Activity Relationship | 1982 |
Structure-activity relationships for the antileishmanial and antitrypanosomal activities of 1'-substituted 9-anilinoacridines.
Topics: Amsacrine; Animals; Antiprotozoal Agents; Humans; Leishmania donovani; Leishmania major; Macrophages; Mice; Mice, Inbred CBA; Models, Chemical; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi; Tumor Cells, Cultured | 1997 |
Radiosensitization of E. coli B/r by 9-anilinoacridines.
Topics: Aminoacridines; Amsacrine; Cobalt Radioisotopes; DNA Repair; DNA, Bacterial; Escherichia coli; Oxygen; Radiation-Sensitizing Agents; Structure-Activity Relationship | 1979 |
Photo-enhancement of the mutagenicity of 9-anilinoacridine derivatives related to the antitumour agent amsacrine.
Topics: Acridines; Aminoacridines; Amsacrine; Antineoplastic Agents; Dose-Response Relationship, Drug; Frameshift Mutation; Light; Mutagenicity Tests; Mutagens; Oxidation-Reduction; Proflavine; Salmonella typhimurium | 1992 |
Mutagenic activities of azido analogues of amsacrine and other 9-anilinoacridines in Salmonella typhimurium and their enhancement by photoirradiation.
Topics: Amsacrine; DNA Damage; Electrophoresis, Agar Gel; Frameshift Mutation; Light; Mutagens; Photochemistry; Plasmids; Salmonella typhimurium | 1992 |
DNA-directed alkylating agents. 2. Synthesis and biological activity of platinum complexes linked to 9-anilinoacridine.
Topics: Alkylating Agents; Amsacrine; Animals; Chelating Agents; Chemical Phenomena; Chemistry; Cisplatin; Diamines; DNA; Drug Resistance; Ethylenediamines; Leukemia P388; Magnetic Resonance Spectroscopy; Molecular Structure; Organoplatinum Compounds; Spectrophotometry, Ultraviolet | 1990 |
Electron transfer-oxy radical mechanism for anti-cancer agents: 9-anilinoacridines.
Topics: Amsacrine; Antineoplastic Agents; DNA Damage; Electron Transport; Free Radicals; Oxidation-Reduction; Structure-Activity Relationship | 1987 |
Computer-automated structure evaluation of antileukemic 9-anilinoacridines.
Topics: Amsacrine; Animals; Antineoplastic Agents; Computer Simulation; Leukemia L1210; Software; Structure-Activity Relationship | 1987 |
Potential antitumor agents. 42. Structure-activity relationships for acridine-substituted dimethyl phosphoramidate derivatives of 9-anilinoacridine.
Topics: Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; DNA; Female; Leukemia L1210; Leukemia P388; Male; Mathematics; Mice; Structure-Activity Relationship | 1984 |
Antitumour activity of substituted 9-anilinoacridines--comparison of in vivo and in vitro testing systems.
Topics: Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Cell Survival; Cells, Cultured; DNA, Neoplasm; Dose-Response Relationship, Drug; Leukemia L1210; Mice; Mice, Inbred DBA | 1981 |
Induction of petite formation in Saccharomyces cerevisiae by experimental antitumour agents. Structure--activity relationships for 9-anilinoacridines.
Topics: Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Kinetics; Leukemia L1210; Mice; Mutagens; Mutation; Saccharomyces cerevisiae; Structure-Activity Relationship | 1981 |
Inhibition of T4 bacteriophage yield by 9-anilinoacridines; comparison with in vivo antitumour activity.
Topics: Acridines; Aminoacridines; Amsacrine; Animals; DNA, Viral; Dose-Response Relationship, Drug; Leukemia L1210; Mice; Structure-Activity Relationship; T-Phages | 1980 |
Kinetics and mechanism of general acid-catalysed thiolytic cleavage of 9-anilinoacridine.
Topics: Acids; Amsacrine; Antineoplastic Agents; Catalysis; Hydrogen-Ion Concentration; Hydrolysis; Hydroxylamines; Kinetics; Mercaptoethanol; Structure-Activity Relationship; Sulfhydryl Compounds | 1995 |
Structure-activity relationships of 9-anilinoacridines as inhibitors of human DNA topoisomerase II.
Topics: Amsacrine; Cell Line; Humans; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1994 |
Structure-activity relationships and modes of action of 9-anilinoacridines against chloroquine-resistant Plasmodium falciparum in vitro.
Topics: Amsacrine; Animals; Antimalarials; Cell Line; Chloroquine; Drug Resistance, Microbial; Humans; Leukemia, T-Cell; Plasmodium falciparum; Structure-Activity Relationship; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1993 |
9-Anilinoacridines as potential antileishmanial agents.
Topics: Amsacrine; Animals; Antiprotozoal Agents; Cell Line; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Macrophages; Mice; Mice, Inbred DBA; Tumor Cells, Cultured | 1993 |
Quantitative structure-activity relationships (QSAR) for 9-anilinoacridines: a comparative analysis.
Topics: Amsacrine; Animals; Antineoplastic Agents; Drug Design; Kinetics; Leukemia L1210; Mice; Structure-Activity Relationship | 1998 |
Synthesis, DNA-cleaving properties and cytotoxicity of intercalating chelidamic acid derivatives.
Topics: Acridines; Amsacrine; Antineoplastic Agents; DNA; DNA Footprinting; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Intercalating Agents; Picolinic Acids; Pyridones; Tumor Cells, Cultured | 1998 |
DNA adducts of 9-anilinoacridine mustards: characterization by NMR.
Topics: Amsacrine; Animals; Base Sequence; Cattle; DNA Adducts; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Sequence Data; Molecular Structure; Spectrometry, Mass, Fast Atom Bombardment | 1999 |
Cleavage of DNA induced by 9-anilinoacridine inhibitors of topoisomerase II in the malaria parasite Plasmodium falciparum.
Topics: Amsacrine; Animals; DNA, Protozoan; Enzyme Inhibitors; Plasmodium falciparum; Topoisomerase II Inhibitors | 2000 |
Solid-phase synthesis of acridine-peptide conjugates and their analysis by tandem mass spectrometry.
Topics: Acridines; Amsacrine; Indicators and Reagents; Models, Molecular; Molecular Structure; Peptides; Spectrometry, Mass, Secondary Ion | 2000 |
Point of attachment and sequence of immobilized peptide-acridine conjugates control affinity for nucleic acids.
Topics: Amino Acids; Amsacrine; Combinatorial Chemistry Techniques; Peptide Library; Peptides; RNA | 2002 |
Synthesis and antiinflammatory evaluation of 9-anilinoacridine and 9-phenoxyacridine derivatives.
Topics: Acridines; Amsacrine; Aniline Compounds; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Degranulation; Cells, Cultured; Drug Screening Assays, Antitumor; Humans; Macrophages; Mast Cells; Mice; Neutrophils; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
Antimalarial 9-anilinoacridine compounds directed at hematin.
Topics: Amsacrine; Animals; Antimalarials; Chloroquine; Erythrocytes; Hemin; Hemolysis; Humans; In Vitro Techniques; Plasmodium falciparum; Protein Binding; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2003 |
Potent antitumor N-mustard derivatives of 9-anilinoacridine, synthesis and antitumor evaluation.
Topics: Amsacrine; Animals; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Injections, Intravenous; Mice; Mice, Nude; Nitrogen Mustard Compounds; Paclitaxel; Structure-Activity Relationship; Tumor Cells, Cultured; Vinblastine; Xenograft Model Antitumor Assays | 2004 |
Potent antitumor 9-anilinoacridines bearing an alkylating N-mustard residue on the anilino ring: synthesis and biological activity.
Topics: Alkylating Agents; Amsacrine; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Nude; Neoplasms; Remission Induction; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2005 |
Synthesis and biological activity of stable and potent antitumor agents, aniline nitrogen mustards linked to 9-anilinoacridines via a urea linkage.
Topics: Acridines; Amsacrine; Aniline Mustard; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Mice; Mice, Nude; Molecular Structure; Rats; Stereoisomerism; Urea; Xenograft Model Antitumor Assays | 2008 |
Synthesis and in vitro cytotoxicity of 9-anilinoacridines bearing N-mustard residue on both anilino and acridine rings.
Topics: Amsacrine; Aniline Compounds; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Mustard Compounds; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2009 |
Synthesis of 9-anilinoacridine triazines as new class of hybrid antimalarial agents.
Topics: Amsacrine; Animals; Antimalarials; Mice; Plasmodium falciparum; Triazines | 2009 |
Polymer conjugates of acridine-type anticancer drugs with pH-controlled activation.
Topics: Amsacrine; Antineoplastic Agents; Cell Line, Tumor; Cell Nucleus; Cell Survival; DNA; Drug Carriers; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Intercalating Agents; Microscopy, Fluorescence; Polymers; Water | 2012 |
Docking studies, synthesis, characterization of some novel oxazine substituted 9-anilinoacridine derivatives and evaluation for their antioxidant and anticancer activities as topoisomerase II inhibitors.
Topics: Amsacrine; Animals; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Mice; Models, Molecular; Molecular Structure; Oxazines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2012 |
Synthesis and preliminary biological evaluation of polyamine-aniline acridines as P-glycoprotein inhibitors.
Topics: Amsacrine; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Humans; K562 Cells; Polyamines | 2014 |
Novel Thiazine Substituted 9-Anilinoacridines: Synthesis, Antitumour Activity and Structure Activity Relationships.
Topics: Amsacrine; Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Male; Mice; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship; Thiazines; Tumor Cells, Cultured | 2019 |
In-silico Design, ADMET Screening, MM-GBSA Binding Free Energy of Some Novel Isoxazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer.
Topics: Amsacrine; Antineoplastic Agents; Breast Neoplasms; Computer Simulation; Drug Design; Ethacridine; Female; Humans; Hydrogen Bonding; Isoxazoles; Models, Molecular; Molecular Dynamics Simulation; Receptor, ErbB-2; Structure-Activity Relationship; Tamoxifen | 2019 |
Expedient synthesis and anticancer evaluation of dual-action 9-anilinoacridine methyl triazene chimeras.
Topics: Amsacrine; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA; DNA Topoisomerases, Type II; Drug Screening Assays, Antitumor; Humans; Intercalating Agents; Structure-Activity Relationship; Topoisomerase II Inhibitors; Triazenes | 2021 |
Pyrazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer - An in-silico approach.
Topics: Amsacrine; Breast Neoplasms; Female; Humans; Ligands; Molecular Docking Simulation; Pyrazoles | 2022 |
Synthesis and Anticancer Evaluation of Sulfur Containing 9-anilinoacridines.
Topics: Amsacrine; Antineoplastic Agents; DNA Topoisomerases, Type II; Humans; Molecular Docking Simulation; Sulfur; Topoisomerase II Inhibitors | 2022 |